Primary Hypercholesterolaemia and Mixed Dyslipidemia
1 clinical trials · Condition
◉ Watch Primary Hypercholesterolaemia and Mixed Dyslipidemia
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia (NCT05621070) | Shanghai Junshi Bioscience Co., Ltd. | 2023-02-03 |
Track Primary Hypercholesterolaemia and Mixed Dyslipidemia automatically
Every clearance here is in the API, with alerts when new ones post.